Bone Marrow Stroma Damage Induced by Chemotherapy for Acute Lymphoblastic Leukemia in Children

Pediatric Research

Volumn 55, Issue 1, 2004, Pages 152-158

  Corazza, Francis ^a   Hermans, Christophe ^b   Ferster, Alina ^b   Fondu, Pierre ^a   Demulder, Anne ^a   Sariban, Eric ^b  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANEMIA; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; BURST FORMING UNIT E; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUPERNATANT;

6-MERCAPTOPURINE; ANTIBODIES; ANTIGENS, CD34; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW CELLS; CELLS, CULTURED; CHILD; CHRONIC DISEASE; COCULTURE TECHNIQUES; CYTOKINES; ERYTHROID PROGENITOR CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MACROPHAGE INFLAMMATORY PROTEIN-1; METHOTREXATE; MYELOID PROGENITOR CELLS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0346992206     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000099773.71438.91     Document Type: Article

References (31)

1. Bhavnani M, Morris Jones PH, Testa NG 1989 Children in long-term remission after treatment for acute lymphoblastic leukaemia show persisting haemopoietic injury in clonal and long-term cultures. Br J Haematol 71:37-41
2. Chang J, Geary CG, Testa NG 1990 Long-term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time. Br J Haematol 75:68-72
3. Gardner RV, Astle CM, Harrison DE 1997 Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy. Exp Hematol 25:495-501
4. Soligo D, Lambertenghi Deliliers G, Quirici N, Servida F, Caneva L, Lamorte G 1998 Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients. Bone Marrow Transplant 21:15-22
5. Straetmans N, Herman P, Van Bockstaele DR, Michaux L, Hagemeijer A, Ferrant A 1998 Haemopoietic defect and decreased expansion potential of bone marrow autografts from patients with acute myeloid leukemia in first remission. Br J Haematol 101:571-581
6. del Canizo C, Lopez N, Caballero D, Fernandez E, Brufau A, Vazquez L, Mateos V, Gutierrez N, San Miguel JF 1999 Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23:901-905
7. Yao M, Bouchet S, Hamois C, Giarratana MC, Laporte JP, Gorin NC, Lopez M, Douay L 1998 Quantitative and qualitative alterations of long-term culture-initiating cells in patients with acute leukaemia in complete remission. Br J Haematol 103:124-128
8. Uhlman DL, Verfaillie C, Jones RB, Luikart SD 1991 BCNU treatment of marrow stromal monolayers reversibly alters haematopoiesis. Br J Haematol 78:304-309
9. Galotto M, Berisso G, Delfino L, Podesta M. Ottaggio L, Dallorso S, Dufour C, Ferrara GB, Abbondandolo A, Dini G, Bacigalupo A, Cancedda R, Quarto R 1999 Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 27:1460-1466
10. Hays EF, Hale L, Villareal B, Fitchen JH 1982 "Stromal" and hemopoietic stem cell abnormalities in long-term cultures of marrow from busulfan-treated Mice. Exp Hematol 10:383-392
11. Corazza F, Beguin Y, Bergmann P, Andre M, Ferster A, Devalck C, Fondu P, Buyse M, Sariban E 1998 Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood 92:1793-1798
12. Fortunel NO, Hatzfeld A, Hatzfeld JA 2000 Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 96:2022-2036
13. Verfaillie CM, Catanzarro PM, Li WN 1994 Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 179:643-649
14. Vilmer E, Suciu S, Ferster A, Bertrand Y, Cavé H, Thyss A, Benoit Y, Dastugue N, Fournier M, Souillet G, Manel AM, Robert A, Nelken B, Millot F, Lutz P, Rialland X, Mechinaud F, Boutard P, Behar C, Chantraine JM, Plouvier E, Laureys G, Brock P, Uyttebroeck A, Margueritte G, Plantaz D, Norton L Francotte N, Gyselinck J, Waterkeyn C, Solbu G, Philippe N, Otten J 2000 Long-term results of the three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukaemia: a CLCG-EORTC report. Leukemia 14:2257-2266
15. Gartner S, Kaplan HS 1980 Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A 77:4756-4759
16. Lagneaux L, Delforge A, Dorval C, Bron D, Stryckmans P 1993 Excessive production of transforming growth factor-β by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood 82:2379-2385
17. Lejeune M, Ferster A, Cantinieaux B, Sariban E 1998 Prolonged but reversible neutrophil dysfunctions differentially sensitive to granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia. Br J Haematol 102:1284-1291
18. Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P 1996 Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro. J Infect Dis 174:800-805
19. Lejeune M, Cantinieaux B, Harag S, Ferster A, Devalck C. Sariban E 1999 Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte-macrophage colony stimulating factors in vitro. Br J Haematol 106:756-761
20. Chaudhary PM, Robinson IB 1991 Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-94
21. Gibson LF, Fortney J, Landreth KS, Piktel D, Ericson SG, Lynch JP 1997 Disruption of bone marrow stromal cell function by etoposide. Biol Blood Marrow Transplant 3:122-132
22. Mayani H, Guilbert LJ, Janowska-Wieczorek A 1993 Functional characterization of fibroblastic cells in long-term marrow cultures from patients with acute myelogenous leukemia. Leukemia 7:1564-1569
23. Carlo-Stella C, Tabilio A, Regazzi E, Garau D. La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G 1997 Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 20:465-471
24. Newell CL, Deisseroth AB, Lopez-Berestein G 1994 Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene. J Leukoc Biol 56:27-35
25. de Vries P, Singer JW 2000 Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents. Exp Hematol 28:916-923
26. Migdalska A, Molineux G, Demuynck H, Evans GS, Ruscetti F, Dexter TM 1991 Growth inhibitory effects of transforming growth factor-beta I in vivo. Growth Factors 4:239-245
27. Zermati Y, Fichelson S, Valensi F, Freyssinier JM, Rouyer-Fessard P, Cramer E, Guichard J, Varet B, Hermine O 2000 Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol 28:885-894
28. Broxmeyer HE, Kim CH 1999 Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp Hematol 27:1113-1123
29. Gilmore GL, DePasquale DK, Shadduck RK 1999 Protective effects of BB-10010 treatment on chemotherapy-induced neutropenia in mice. Exp Hematol 27:195-202
30. Cazzola M, Mercuriali F, Brugnara C 1997 Use of recombinant erythropoietin outside the setting of uremia. Blood 89:4248-4267
31. Oberhoff C, Neri B, Amadori D, Petry KU, Gamucci T, Rebmann U, Nowrousian MR, Voigtmann R, Monfardini S, Armand JP. Herrmann R, Netter-Pinon J, Tubiana-Mathieu N, Zwierzina H 1998 Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study. Ann Oncol 9:255-260